Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"health impact"

Slides: 1–12 of 15
Add to tray Remove from tray

Health Impact of Head and Neck Cancer in the United States

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: head and neck cancer | epidemiology
An estimated 80 million American adults (1 in 3) have one or more forms of cardiovascular disease. Among these adults, 38,100,000 are estimated to be age 60 or older, and about 16.8 million adults have ischemic heart disease, also known as coronary heart disease.
Add to tray Remove from tray

Health Impact of Cardiovascular Disease in the United States (1)

Presentation: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Patients With Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Keywords: cardiovascular disease | coronary heart disease | ischemic heart disease | health impact
Cardiovascular disease has been the leading cause of death in the United States in every year since 1900, except in 1918, accounting for more deaths than any other single cause or group of causes of death. Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents, and diabetes mellitus combined. According to current data, nearly 2,400 Americans die of cardiovascular disease each day, an average of 1 death every 37 seconds.
Add to tray Remove from tray

Health Impact of Cardiovascular Disease in the United States (2)

Presentation: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Patients With Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Keywords: cardiovascular disease | ischemic heart disease | health impact
Add to tray Remove from tray

Background: Health Impact of GERD

Presentation: Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update
Keywords: GERD | antacids | acid-reducing medication | symptoms | characteristics | background
Add to tray Remove from tray

Background: Public Health Impact

Presentation: Comparing Medications for Adults With Type 2 Diabetes
Keywords: chronic illness | cost | economic burden | type 2 diabetes | public health
Add to tray Remove from tray

Background: Adverse Clinical Outcomes Associated With Obstructive Sleep Apnea

Presentation: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults
Keywords: background | comorbidity | epidemiology | outcomes | public health impact
Add to tray Remove from tray

Outline of Material

Presentation: Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatic arthritis | JCA | juvenile chronic arthritis | DMARDs | disease-modifying | antirheumatic | antirheumatic | rheumatic
Add to tray Remove from tray

Health Impact of Juvenile Idiopathic Arthritis

Presentation: Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatic arthritis | JCA | juvenile chronic arthritis | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic
Add to tray Remove from tray

Health Impact of Rheumatoid Arthritis

Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | prevalence
Add to tray Remove from tray

Outline of Material

Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: CF | HGH | cystic fibrosis | human growth hormone | recombinant human growth hormone | rhGH
Add to tray Remove from tray

Health Impact of Cystic Fibrosis in the United States

Presentation: Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
Keywords: cystic fibrosis | health impact | incidence | genetic disease | childhood | CF | rhGH | recombinant human growth hormone | human growth hormone | HGH
Add to tray Remove from tray

Background: Public Health Impact

Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: chronic kidney disease | prevalence | stages | risk factors
Pages: [1] 2 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364